CMS’s Nationwide Moratorium on New Hospice and Home Health Enrollments: Operational, Transactional, and Enforcement Risks for Existing Providers, Healthcare Organizations, and Investors

Healthcare providers, healthcare professionals, hospitals, investors, and private equity-backed healthcare platforms should prepare for increasing operational, transactional, reimbursement, compliance, and enforcement risks as CMS freezes new Medicare enrollment for home health agencies and hospice providers nationwide.

The Centers for Medicare & Medicaid Services (“CMS”) recently announced a six-month nationwide moratorium on the enrollment of new Medicare home health agencies (“HHAs”) and hospice providers, citing serious fraud concerns and broader federal program integrity initiatives targeting these sectors. According to CMS, the moratorium is intended to prevent fraudulent providers from entering the Medicare program while supporting ongoing efforts involving investigations, payment suspensions, revocations, deactivations, and other enforcement actions involving hospice and home health providers nationwide. CMS stated that fraudulent providers and schemes can “migrate” geographically and described certain fraud patterns as “viral,” concluding that nationwide enrollment restrictions were necessary to prevent providers from relocating problematic operations into new markets.

Although the immediate headline involves freezing new Medicare provider enrollment, the larger operational and financial implications may involve existing Medicare-enrolled hospice and home health agencies already operating throughout the country. When the federal government restricts entry into an entire healthcare sector nationwide, existing Medicare-enrolled providers suddenly become more strategically valuable to healthcare organizations, professionals, and private equity-backed platforms seeking to enter or expand within these markets. At the same time, existing Medicare-enrolled hospice and home health agencies may carry substantially greater reimbursement, operational, compliance, and enforcement risk that could significantly impact the value of the business due to Medicare enrollment status, billing practices, ownership structure, operational compliance, referral relationships, and undisclosed government scrutiny.

Why the Moratorium Matters

The moratorium may create heightened transactional and operational risks for existing providers, healthcare organizations, investors, and healthcare professionals involved in acquisitions, ownership transfers, restructurings, management arrangements, or investments involving hospice and home health agencies. Transactions involving agencies with pending overpayment determinations, payment suspensions, recoupment actions, billing irregularities, whistleblower allegations, government investigations, bankruptcy proceedings, or undisclosed compliance concerns may present significantly greater exposure in the current environment.

Existing restrictions involving ownership changes and Medicare enrollment may also become more significant as healthcare organizations, investors, and private equity-backed platforms evaluate potential acquisitions or investments involving existing hospice and home health providers. CMS also possesses broad authority involving enrollment denials, revocations, deactivations, payment suspensions, and heightened provider screening.

Implications for Hospitals, Physicians, and Affiliated Professionals

Hospitals, physicians, and healthcare professionals should not assume this development affects only hospice and home health operators. Many hospitals and healthcare organizations depend upon home health agencies and hospice providers to support discharge planning, continuity of care, post-acute services, chronic care management, and end-of-life care coordination for vulnerable patient populations. Physicians and healthcare professionals may also be connected to these providers as owners, investors, medical directors, certifying physicians, referral sources, contractors, or affiliated professionals.

As federal scrutiny intensifies within these sectors, operational disruption and enforcement activity may extend beyond the hospice or home health agency itself and into broader referral, operational, financial, and ownership relationships involving healthcare organizations and affiliated professionals.

Key Takeaway

The larger issue may no longer be whether fraud exists within isolated hospice or home health agencies. CMS is now signaling that hospice and home health fraud is being treated as a nationwide healthcare enforcement and program integrity priority with potentially significant implications for providers, healthcare organizations, healthcare professionals, investors, and patients relying on these services.

Healthcare organizations, investors, healthcare professionals, and operational leaders affiliated with hospice and home health providers may wish to evaluate ownership structures, pending transactions, enrollment status, billing practices, referral relationships, operational controls, reimbursement exposure, and existing government scrutiny before operational disruptions, payment suspensions, recoupment activity, or enforcement actions arise.

This publication is intended for general informational purposes only and does not constitute legal advice or a solicitation to provide legal services. The information in this publication is not intended to create, and receipt of it does not constitute, a lawyer-client relationship. Readers should not act upon this information without seeking professional legal counsel. The views and opinions expressed herein represent those of the individual author(s) only and are not necessarily the views of Clark Hill PLC or Clark Hill Solicitors LLP. Although we attempt to ensure that postings on our website are complete, accurate, and up to date, we assume no responsibility for their completeness, accuracy, or timeliness.